Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Methotrexate tablets (Maoxiang)

1. All types of acute leukemia, especially acute lymphoblastic leukemia, malignant lymphoma, non Hodgkin's lymphoma, mycosis fungoides and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas and psoriasis; 3. breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer. More role
App download minus 10 yuan
Common name:
Methotrexate Tablets
Product No.:
B14202323911
Approval No.:
Gyzz h22022674 (inquired by the State Drug Administration)
Jianke price:
¥190.00
Product specification:
2.5mg*16s 2.5mg*100s
Manufacturer:
Tonghua Maoxiang Pharmaceutical Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
Related classification
People who browse this product also browse
    Your recent history
      Wechat sweep: Jianke
      Health care doctor
      • Product introduction
      • instructions
      • Qualification certificate
      • Relevant information
      Product name Methotrexate tablets (Maoxiang)
      Main raw materials Methotrexate.
      Main role 1. All types of acute leukemia, especially acute lymphoblastic leukemia, malignant lymphoma, non Hodgkin's lymphoma, mycosis fungoides and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas and psoriasis; 3. breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer.
      Product specification 2.5mg*100s
      Usage and dosage Oral administration for adults is 5 ~ 10mg once a day, 1 ~ 2 times a week, and the safe amount of a course of treatment is 50 ~ 100mg. For maintenance treatment of acute lymphoblastic leukemia, 15 ~ 20mg / m2 once a week.
      manufacturing enterprise Tonghua Maoxiang Pharmaceutical Co., Ltd
      Jianke commitment
      • Genuine guarantee, formal invoice

        Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

      • Private packaging, privacy protection

        When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

      • Efficient logistics and safe arrival

        All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

      • Three warehouses to ensure inventory

        Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

      [drug name] Methotrexate tablets (Maoxiang)

      [common name] Methotrexate Tablets

      [specification and model] 2.5mg*100s

      [manufacturer] Tonghua Maoxiang Pharmaceutical Co., Ltd

      [drug type] Western medicine

      [approval No.] Gyzz h22022674

      [validity period] 24 months

      [functional indications] 1. All types of acute leukemia, especially acute lymphoblastic leukemia, malignant lymphoma, non Hodgkin's lymphoma, mycosis fungoides and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas and psoriasis; 3. breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer.

      [usage and dosage] Oral administration for adults is 5 ~ 10mg once a day, 1 ~ 2 times a week, and the safe amount of a course of treatment is 50 ~ 100mg. For maintenance treatment of acute lymphoblastic leukemia, 15 ~ 20mg / m2 once a week.

      [adverse reactions] 1. Gastrointestinal reactions, including stomatitis, lip ulcer, pharyngitis, nausea, vomiting, abdominal pain, diarrhea and gastrointestinal bleeding. Anorexia is common, occasionally pseudomembranous or hemorrhagic enteritis, etc; 2. Liver function impairment, including jaundice, alanine aminotransferase and alkaline phosphatase, γ- Glutamyl transpeptidase is increased. Long term oral administration can lead to hepatocyte necrosis, fatty liver, fibrosis and even cirrhosis; 3. During high-dose application, hyperuricemia nephropathy may occur due to the deposition of this product and its metabolites in renal tubules. At this time, hematuria, proteinuria, oliguria, azotemia or even uremia may occur; 4. Long term medication can cause cough, shortness of breath, pneumonia or pulmonary fibrosis; 5. Bone marrow suppression; It is mainly leucopenia and thrombocytopenia. Long term oral low dose can lead to obvious bone marrow suppression, anemia and thrombocytopenia with skin or visceral bleeding; 6. Hair loss, skin redness, pruritus or rash; 7. Infection may occur when leukocytes are low.

      [precautions] 1. The mutagenicity, teratogenicity and carcinogenicity of this product are lighter than those of alkylating agents, but there is a potential risk of secondary tumors after long-term use; 2. Although the effect on reproductive function is smaller than that of alkylating anticancer drugs, it can also lead to amenorrhea and sperm reduction or lack, especially after long-term application of large doses, but it is generally not serious and sometimes irreversible; 3. This product is forbidden in case of extreme systemic failure, cachexia or concurrent infection and heart, lung, liver and kidney dysfunction. Peripheral hemogram, such as white blood cells lower than 3500 / mm [sup] 3 [/ sup] or platelets lower than 50000 / mm3, should not be used; Please read the instructions carefully and follow the doctor's advice.

      [taboo] It is forbidden for patients who are known to be highly allergic to this product.

      [listing Permit Holder] Tonghua Maoxiang Pharmaceutical Co., Ltd

      [packaging unit] bottle

      [main ingredients] Methotrexate.

      [character] This product is light orange yellow tablets.

      [applicable population] unlimited

      [medication for pregnant and lactating women] Because this product has teratogenic effect and is discharged from milk, pregnancy and lactation are prohibited during the medication period.

      [medication for children] This product has not been tested and there is no reliable reference.

      [medication for elderly patients] This product has not been tested and there is no reliable reference.

      [storage] Seal and keep in a cool place.

      Praise degree

      zero%

        reminder

        Dear customer:

        In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

        Methotrexate tablets (Maoxiang)

        ¥190.00

        reminder

        To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

        Please enter the correct verification code!
        Loding...
        Can't see clearly. Change one

        Dear customer:

        Your callback failed this time. Please re-enter the verification code to try. Thank you!